Severe acute respiratory syndrome (SARS) was coined by the World Health Organization (WHO)[^1^](#b1){ref-type="ref"} to describe an unusual form of severe pneumonia that first appeared in Guangdong Province, China, in November 2002. On 12 March 2003, the WHO issued a global alert on SARS[^2^](#b2){ref-type="ref"}. At the time of writing, there were 1755 confirmed cases of SARS with 299 deaths in Hong Kong[^3^](#b3){ref-type="ref"}. A treatment regime of ribavirin and systemic corticosteroid was reported in adults and children[^4^](#b4){ref-type="ref"}, [^5^](#b5){ref-type="ref"}, [^6^](#b6){ref-type="ref"}. A novel coronavirus was suggested to be the cause of SARS[^4^](#b4){ref-type="ref"}, [^7^](#b7){ref-type="ref"}. It was proposed to be named after the late Dr Carlo Urbani who alerted the WHO to 'something strange and different' on 5 March 2003[^7^](#b7){ref-type="ref"}. We report here five children and teenagers who showed evidence of SARS coronavirus infection.

We analyzed, retrospectively, five children who were found to have pneumonia with evidence of the SARS coronavirus infection, that is, positive reverse‐transcriptase -- polymerase chain reaction (RT‐PCR) and/or serological evidence of infection. Details of RT‐PCR and serological tests have been published previously[^4^](#b4){ref-type="ref"}. Clinical features, investigation results, treatment and outcome are listed in [Table 1](#t1){ref-type="table"}.

###### 

** **Clinical features, investigation results, treatment and outcome of children infected by the severe acute respiratory syndrome coronavirus

  Case no.                                                                                   1                                          2                           3                                                                               4                                          5
  ------------------------------------------------------------------------------------------ ------------------------------------------ --------------------------- ------------------------------------------------------------------------------- ------------------------------------------ ---------------------------------
  Age (years)                                                                                15                                         2                           15                                                                              Post‐conceptional  38 weeks                13
  Gender (M/F)                                                                               F                                          F                           F                                                                               M                                          M
  Clinical features                                                                                                                                                                                                                                                                            
  Highest body temperature (°C)                                                              40.5                                       38.6                        39.6                                                                            38 .5                                      38.9
  Duration of fever (days)                                                                   12                                         5                           5                                                                               1                                          7
  Respiratory distress                                                                       No                                         No                          No                                                                              Yes                                        No
  Runny nose                                                                                 No                                         No                          No                                                                              No                                         No
  Cough                                                                                      No                                         Yes                         Yes                                                                             Yes                                        Yes
  Sore throat                                                                                No                                         No                          No                                                                              No                                         No
  Chills/rigors                                                                              Yes                                        No                          Yes                                                                             No                                         Yes
  Myalgia                                                                                    No                                         No                          No                                                                              No                                         Yes
  Headache                                                                                   No                                         No                          No                                                                              No                                         No
  Others                                                                                     No                                         Malaise                     No                                                                              Hypothermia                                Malaise
  Close contact history with SARS                                                            Nil                                        Father(?)                   Nil                                                                             Nil                                        Nil
  Laboratory findings                                                                                                                                                                                                                                                                          
  Lowest Lymphocyte count ( × 10^9^/L)[^†^](#t1n2){ref-type="target"}                        0.7  (Day 7)                               0.9  (Day 4)                0.8  (Day 4)                                                                    2.4  (Day 4)                               1.8  (Day 4)
  Lowest platelet count ( × 10^9^/L)[^†^](#t1n2){ref-type="target"}                          151  (Day 7)                               197  (Day 4)                161  (Day 4)                                                                    404  (Day 4)                               137  (Day 8)
  Highest serum                                                                              NA                                         353                         249                                                                             1143                                       277
  (range: 165--395)[^†^](#t1n2){ref-type="target"}                                                                                      (Day 3)                     (Day 4)                                                                         (Day 3)                                    (Day 9)
  Highest serum ALT (U/L) (range: \< 33)[^†^](#t1n2){ref-type="target"}                      NA                                         19  (Day 3)                 12  (Day 3)                                                                     312  (Day 3)                               25  (Day 9)
  D‐dimer (mcg/mL) (normal \< 0.2 µg/mL)[^†^](#t1n2){ref-type="target"}                      NA                                         0.5--2.0  (Day 6)           0.5--2.0  (Day 3)                                                               0.3  (Day 4)                               2.0--8.0
  Radiological findings                                                                                                                                                                                                                                                                        
  Initial chest radiograph                                                                   Right upper zone air‐space consolidation   RLZ interstitial haziness   Right upper zone air‐space change and right middle zone interstitial haziness   Right lower zone air‐space consolidation   Bilateral interstitial haziness
  *Treatment and outcome*                                                                                                                                                                                                                                                                      
   Oral ribavirin                                                                            No                                         Yes                         Yes                                                                             No                                         Yes
   IV ribabirin                                                                              No                                         Yes                         No                                                                              Yes                                        No
   Oral prednisolone/IV hydrocortisone                                                       No                                         Yes                         No                                                                              No                                         No
   Ventilatory support                                                                       No                                         No                          No                                                                              CPAP 5 cm water                            No
   Maximum oxygen requirement                                                                21%                                        21%                         21%                                                                             45% oxygen                                 21%
   SARS coronavirus RT‐PCR[^†^](#t1n2){ref-type="target"}, [^‡^](#t1n1){ref-type="target"}   NPA + ve  (Day 4)                          NPA + ve  (Day 3)           NPA -- ve  (Day 1)                                                              NPA + ve                                   NPA‐ve  Stool + ve (Day 3)
   SARS coronavirus serology [^‡^](#t1n1){ref-type="target"}                                 From \<25--1600                            Negative                    From \<25--200                                                                  From \<25--200                             From \<25--200
   Outcome                                                                                   Full recovery                              Full recovery               Full recovery                                                                   Full recovery                              Full recovery

^†^ Number of days after onset for specimens collection; ^‡^ Performed by Government Virus Unit, Hong Kong SAR Government. Primers used in RT‐PCR assay were COR‐1 and COR‐2. [^9^](#b9){ref-type="ref"}

ALT, alanine aminotransferase; CPAP, continuous positive airway pressure; NA, not available; NPA, nasopharyngeal aspirate; RT‐PCR, reverse transcriptase‐polymerase chain reaction; SARS, severe acute respiratory syndrome.

Case 1 {#ss1}
======

The first case was a 15‐year‐old girl. There was no SARS contact nor history of travel to southern China. She was admitted on 17 March 2003 after 4 days of fever, cough and chills. The highest temperature was 39.3°C. She had no respiratory distress during the whole period of hospitalization. Chest X‐ray initially showed right upper lobe segmental consolidation. She had lymphopenia of 0.7 × 10^9^/L on admission, which normalized on Day 5. She was initially treated with erythromycin. As the fever persisted, intravenous amoxycillin/clavulanic acid was started on Day 5. The fever settled 8 days after admission and she was discharged on Day 9 with amoxycillin/clavulanic acid. The result of the nasopharyngeal aspirate for SARS coronavirus RT‐PCR was found to be positive after discharge. The immunofluorescence assay for SARS coronavirus antibody titre also showed a significant rise from \<25 to 1600 for SARS coronavirus. There was no recurrence of fever or cough. The repeated chest X‐ray taken 1 month later was normal.

Case 2 {#ss2}
======

The second case was a 2‐year‐old girl who presented on 4 April 2003 with high fever for 2 days, cough and malaise. There was no respiratory distress. Chest radiograph at presentation showed right lower zone interstitial infiltrates. Her father had been to mainland China in late February, following which he developed high fever, cough, malaise and myalgia for a week with spontaneous recovery. Radiographic examination of the father\'s chest showed bilateral interstitial infiltrates. He refused further investigations since his symptoms had already subsided and he was well afterwards. The child was started on oral clarithromycin and amoxicillin initially. The fever persisted and intravenous cefuroxime and oral ribavirin were commenced. Coronavirus was identified on Day 3 of admission from her nasal pharyngeal aspirate by RT‐PCR. Ribavirin was changed from oral to intravenous administration and oral prednisolone at 2 mg/kg per day was also started. Her fever subsided on Day 3 of admission, 24 h after commencement of ribavirin. Her condition remained stable. No progressive changes were evident on follow‐up chest radiographs. Liver functions and hematological picture remained normal except lymphopenia at presentation. The lowest lymphocyte count was 0.9 × 10^9^ on Day 3 of admission. There were no adverse effects from steroids or ribavirin. She was discharged after 21 days of hospitalization and has remained well at subsequent follow‐up visits. The steroid therapy was weaned off over 3 months.

Case 3 {#ss3}
======

The third case was a 15‐year‐old girl who was admitted on 5 April 2003. She presented with a 1 day history of fever (39°C), chill and cough. There was no history of SARS contact nor history of travel outside Hong Kong. The only abnormal physical finding was inspiratory crackles over the right chest. Fever persisted despite amoxycilin and clarithromycin. It was changed to intravenous cefotaxme and oral ribavirin 3 days after admission. Fever resolved within 24 h. No systemic corticosteroid was given. She made a full recovery.

Case 4 {#ss4}
======

The fourth case was a 56‐day‐old male premature infant, born at 30 weeks gestation. He was admitted to the pediatric department of another hospital on 6 April for respiratory distress with tachypnea and subcostal insucking. On admission, the rectal temperature was 35.8°C. No other abnormal signs were found. Pulse oximetry revealed a low oxygen saturation, 84%, in room air. Chest radiograph showed consolidation of the right lower zone. He was treated for bacterial pneumonia with intravenous ampicillin, cefotaxime and erythromycin and oxygen. A fever of 38.5°C was detected on Day 3 of hospitalization. He was transferred to the Department of Paediatrics, Kwong Wah Hospital, Kowloon, Hong Kong, for intensive care because of progressive respiratory distress with increasing oxygen requirement. After admission to the intensive care unit, nasal continuous positive airway pressure (CPAP) with pressure of 5cmH~2~O and 2 L/min oxygen were given. Oxygen saturation increased from 94 to 96% and tachypnea was improved with less subcostal insucking. He was weaned off nasal CPAP after 12 h. Supplemental oxygen was discontinued after 5 days in intensive care. He was transferred back to another hospital for convalescent care. The nasopharyngeal aspirate for SARS coronavirus was found to be positive and ribavirin was started in view of the positive RT‐PCR result and young age although he was clinically well.

Case 5 {#ss5}
======

The fifth case was a 13‐year‐old boy admitted on 4 April. He presented with 3 days of high fever, cough, malaise, myalgia and diarrhea. He also complained of chills and rigors. He had no history of contact to SARS. Chest Xray showed bilateral interstitial infiltrate. Oral amoxycillin and clarithromycin were started on admission. The fever persisted and amoxycillin was replaced by intravenous cefotaxime on Day 2 of admission. However, his symptoms did not respond and chest radiograph on Day 3 showed progressive changes to bilateral lobar involvement. Ribavirin was added on Day 4 of admission. The fever subsided after 2 days of oral ribavirin. No systemic cortisteroid was given. SARS coronavirus was isolated from a stool sample but not from nasal pharyngeal aspirate. His condition remained satisfactory and he was discharged after 21 days. No adverse effect was noted with the use of ribavirin. He remains well after the 1 month follow‐up. Subsequent chest radiographs were normal but SARS coronavirus remained detectable from his stool sample up to 1 month after the illness.

Discussion {#ss6}
==========

In line with a previous report from Hong Kong[^5^](#b5){ref-type="ref"}, children had less severe symptoms than adults in the current series. However, SARS coronavirus had a more adverse impact on neonates as illustrated by our case who required CPAP and 40% oxygen. This was similar to the observation in animals[^8^](#b8){ref-type="ref"}. However, this neonate only required a brief period of non‐invasive CPAP and improved without ribavirin and systemic corticosteroid, in contrast to the experience in adults[^6^](#b6){ref-type="ref"}. Similar to previous reports in adults and children[^5^](#b5){ref-type="ref"}, [^6^](#b6){ref-type="ref"}, fever was a ubiquitous feature during the course of SARS in the current series. Fever in adolescents (range of highest temperature, 38.9 to 40.5°C) were significantly higher than toddlers/infants (range of highest temperarure, 38.5 to 38.6°C). The duration of fever was also longer in adolescents (5--12 days) than toddlers/infants (1--5 days). The lactate dehydrogenase level was much higher in the severe neonatal case who required intensive care. This was similar to that reported by Lee *et al* [^6^](#b6){ref-type="ref"}.

In the current series, all three adolescents had a rather benign course in marked contrast to previous case series that reported oxygen dependency in four out of five adolescents. The reason behind the difference was not clear. It is noteworthy that all current cases had no contact history of SARS, unlike the previously reported cases. It was interesting to note that the only adolescent, who was not given ribavirin, had a much longer duration of fever than the two who were treated with ribavirin (12 days vs 5--7 days). In contrast to previous reports[^5^](#b5){ref-type="ref"}, [^6^](#b6){ref-type="ref"}, history of contact was positive in only one out of five cases. Hence, absence of contact history has a low negative predictive value even in a time of major outbreak, and absence of contact history should not dissuade one from adopting full precaution in dealing with febrile patients in Hong Kong. The transmission route(s) of these patients without contact history remain elusive.

This case series suggests that SARS coronavirus is milder in children and adolescents. Further studies are required to confirm the effectiveness of ribavirin in shortening the duration of fever in adolescents even though the current series suggested that duration of fever appeared to be shorter in those treated with ribavirin.
